Paper7105002
Clonal analysis of the stepwise appearance of anchorage independence and tumorigenicity in CAK, a permanent line of mouse cells.
Thomassen DG and 1 other. Cancer Res, 1982. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Clonal analysis of the stepwise appearance of anchorage independence and tumorigenicity in CAK, a permanent line of mouse cells. Papers, record 7105002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7105002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Animals | |
| Cell Line | |
| Clone Cells | |
| Diploidy | |
| Embryo, Mammalian | |
| Metaphase | |
| Methylnitronitrosoguanidine | |
| Mice | |
| Mice, Inbred Strains | |
| Phenotype |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| GM 06983 | NIGMS NIH HHS | United States | PubMed | PubMed | |
| GM-07133 | NIGMS NIH HHS | United States | T32GM007133 | PubMed and NIH | NIH RePORTER |
| P30 CA 14520 | NCI NIH HHS | United States | P30CA014520 | PubMed and NIH | NIH RePORTER |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10077604 | Relative rates of insertion and deletion mutations in a microsatellite sequence in cultured cells. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10077604 | PubMed |
| 6469274 | Establishment and characterization of cell lines from the Walker carcinoma 256 able to grow in suspension culture and deficient in thymidine kinase. | In Vitro | 1984 | https://conductscience.org/library/papers/6469274 | PubMed |
| 4030628 | The majority of independently transformed BHK cell clones share a single functional lesion which determines anchorage independence and influences tumorigenicity. | In Vitro Cell Dev Biol | 1985 | https://conductscience.org/library/papers/4030628 | PubMed |
| 3893685 | Quantitative genetic analysis of tumor progression. | Cancer Metastasis Rev | 1985 | https://conductscience.org/library/papers/3893685 | PubMed |
| 3851695 | In vitro cloning of tumor stem cells in semi-solid media containing agar and agarose. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3851695 | PubMed |
| 3610950 | Early passage primate cell immortality is independent of tumorigenicity. | In Vitro Cell Dev Biol | 1987 | https://conductscience.org/library/papers/3610950 | PubMed |
| 3131765 | Characterization of mutagen-activated cellular oncogenes that confer anchorage independence to human fibroblasts and tumorigenicity to NIH 3T3 cells: sequence analysis of an enzymatically amplified mutant HRAS allele. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3131765 | PubMed |
| 2808222 | Comparative properties of untreated and N-nitrosobenzylmethyl-amine-transformed rat esophageal epithelial cell lines. | In Vitro Cell Dev Biol | 1989 | https://conductscience.org/library/papers/2808222 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7105002
GET https://conductscience.org/api/papers/v1/7105002/authors